Revance Therapeutics CEO: Challenging Allergan | Mad Money | CNBC
- 80
A new wrinkle to an old treatment helped the stock of Revance Therapeutics nearly double in 2017. Could its competitive streak against Allergan help push the company even higher? Jim Cramer...
CNBC
Welcome to the official YouTube channel for CNBC. From 'Wall Street' to 'Main Street' to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more.
For real-time news updates from around the world, visit: http://www.cnbc.com
For CNBC's primetime TV lineup, visit http://tv.cnbc.com
For CNBC's International YouTube channel, visit: http://www.youtube.com/cnbcinternational
